AtriCure, Inc.

📍 Mason, United States🗓 Founded 2000👥 1,030 employees💰 Last funded Dec 2019
AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first and only medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide, with more than 150,000 implanted to date. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2000
Founded
Investor geography1 country
United States
2
Frequently asked questions
Who invested in AtriCure, Inc.?
AtriCure, Inc. has 2 investors on record on gritt.io and 1 late-stage investors.
When did AtriCure, Inc. last raise funding?
The most recent investment in AtriCure, Inc. recorded on gritt.io was in December 2019.
When was AtriCure, Inc. founded?
AtriCure, Inc. was founded in 2000.
What industry is AtriCure, Inc. in?
AtriCure, Inc. operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is AtriCure, Inc. based?
AtriCure, Inc. is headquartered in Mason, United States.